Explore 3 Stock Ideas & Industry Insights Download Free Report

Rapid Therapeutic Science Lab inc

Company price
0.0004 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
9500
Market Cap
0.01M

Momentum Score

…

Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in De Leon, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.01
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-1.12
ROE
-
Net Debt
3.45M
ROCE
2.70%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-03-31 2022-12-31 2022-03-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-03-31 2022-12-31 2022-03-31 2021-12-31
Income before tax -0.18M -1.79M -1.79M -2.87M -2.87M
Net income -0.18M -1.69M -1.69M -4.20M -4.20M
Selling general administrative - 1.24M 1.24M 2.11M 2.11M
Gross profit -0.02M 0.00M 0.00M 0.00M 0.00M
Reconciled depreciation - 0.02M 0.02M 0.06M 0.06M
Ebit -0.08M -1.26M -1.26M -2.17M -2.17M
Ebitda -0.06M -1.24M -1.24M -2.11M -2.11M
Depreciation and amortization 0.02M 0.02M 0.02M 0.06M 0.06M
Operating income -0.08M -1.26M -1.26M -2.17M -2.17M
Other operating expenses 0.08M 1.26M 1.26M 2.17M 2.17M
Interest expense 0.10M 1.90M 1.90M 1.33M 1.33M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Net interest income - -1.90M -1.90M -1.33M -1.33M
Income tax expense - -0.10M -0.10M 1.33M 1.33M
Total revenue - 0.00M 0.00M 0.00M 0.00M
Total operating expenses 0.06M 1.26M 1.26M 2.17M 2.17M
Cost of revenue 0.02M 0.00M 0.00M 0.00M 0.00M
Total other income expense net -0.10M -0.53M -0.53M -0.70M -0.70M
Net income from continuing ops - -1.79M -1.79M -2.87M -2.87M
Net income applicable to common shares - - - -2.87M -2.87M
Breakdown 2024-12-31 2023-03-31 2022-12-31 2022-03-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-03-31 2022-12-31 2022-03-31 2021-12-31
Total assets 0.97M 2.25M 2.25M 2.20M 2.20M
Intangible assets - 0.17M 0.17M 0.17M 0.17M
Other current assets - 0.06M 0.06M 0.05M 0.05M
Total liab 4.05M 5.40M 5.40M 3.58M 3.58M
Total stockholder equity -3.08M -3.14M -3.14M -1.38M -1.38M
Other current liab 0.39M 0.67M -0.22M 1.09M 0.62M
Common stock 0.02M 0.01M 0.01M 0.19M 0.19M
Capital stock - 0.01M 0.01M 0.19M 0.19M
Retained earnings -10.47M -10.32M -10.32M -8.52M -8.52M
Cash - -0.38M -0.38M 0.19M 0.19M
Total current liabilities 4.05M 4.97M 4.97M 3.05M 3.05M
Current deferred revenue - - - 0.05M 0.05M
Net debt 3.45M 4.21M 4.21M 1.79M 1.79M
Short term debt 3.45M 3.40M 3.40M 1.46M 1.46M
Short long term debt - 3.30M 3.30M 1.38M 1.38M
Short long term debt total 3.45M 3.83M 3.83M 1.99M 1.99M
Other stockholder equity 7.37M 7.17M 7.17M 6.95M 6.95M
Property plant equipment - - - 1.61M 1.61M
Total current assets 0.18M 0.23M 0.23M 0.42M 0.42M
Net tangible assets - - - -1.55M -1.55M
Net receivables - 0.38M 0.38M - -
Long term debt - 0.15M 0.15M 0.15M 0.15M
Inventory 0.18M 0.18M 0.18M 0.18M 0.18M
Accounts payable 0.21M 0.89M 0.89M 0.47M 0.47M
Non currrent assets other - 0.17M 0.17M - -
Non current assets total 0.79M 2.02M 2.02M 1.78M 1.78M
Capital lease obligations - 0.38M 0.38M 0.45M 0.45M
Breakdown 2023-03-31 2022-12-31 2022-03-31 2021-12-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-12-31 2022-03-31 2021-12-31 2021-03-31
Investments -0.04M -0.04M -0.29M -0.29M -
Change to liabilities - - 0.08M 0.08M 0.03M
Total cashflows from investing activities - - -0.29M -0.29M -0.11M
Net borrowings - - 1.61M 1.61M 0.27M
Total cash from financing activities 1.00M 1.00M 2.19M 2.19M 2.36M
Change to operating activities - - -0.03M -0.03M 0.07M
Net income -1.79M -1.79M -2.87M -2.87M -2.36M
Change in cash -0.19M -0.19M -0.31M -0.31M 0.37M
Begin period cash flow 0.19M 0.19M 0.50M 0.50M 0.14M
End period cash flow 0.00M 0.00M 0.19M 0.19M 0.50M
Total cash from operating activities -1.15M -1.15M -2.21M -2.21M -1.88M
Issuance of capital stock 0.00M 0.00M 0.58M 0.58M -
Depreciation 0.02M 0.02M 0.06M 0.06M 0.11M
Change to inventory - - 0.01M 0.01M -0.19M
Other cashflows from financing activities 1.29M 1.29M 1.91M -0.29M -0.09M
Change to netincome - - -0.59M -0.59M 0.46M
Capital expenditures 0.04M 0.04M 0.29M 0.29M 0.11M
Change in working capital 0.20M 0.20M 0.07M 0.07M -
Stock based compensation 0.02M 0.02M 0.02M 0.02M -
Other non cash items 0.40M 0.40M 1.15M 1.15M -
Free cash flow -1.19M -1.19M -2.50M -2.50M -

Peer Comparison*

Sector: Financial Services Industry: Shell Companies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RTSL
Rapid Therapeutic Science Lab inc
-
-%
0.00 - - 16784.09 136.70 79847.58 5.72
CLUS
CLUS
-
-%
200.00 - - 0.09 0.92 0.72 -8.97
SGDH
Sgd Holdings Ltd
-0.89
88.82%
0.11 - - 59741.55 0.56 2.50 -162.10
LION
Lionsgate Studios Holding Corp.
1.66
13.22%
14.22 - 23.31 1.13 1.35 2.37 5.55
QKIE
QKIE
-
-%
1.88 - - 470.20 - - -

Profile*

Rapid Therapeutic Science Lab inc

Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in De Leon, Texas.

558 County Road 472, De Leon, TX, United States, 76444

800 497 6059

3

Name Title Year Born
Mr. Donal R. Schmidt Jr. Pres, CEO & Chairman 1961
Mr. D. Hughes Watler Jr. CFO & Director 1949
Dr. Duane Drinkwine Ph.D. Chief Science Officer NA
Mr. Ryan C. Johnson VP of Marketing 1975
Mr. Frank Gill Chief Isolate Laboratory Technician NA
Mr. Sean Paul Berrier Sr. VP NA
Mr. Donal R. Schmidt Jr. President, CEO & Chairman 1961
Dr. Duane C. Drinkwine Ph.D. Chief Science Officer NA
Mr. Ryan C. Johnson Vice President of Marketing 1975
Mr. Sean Paul Berrier Senior Vice President NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…